Follow the Pharma Outreach Series

Follow the live outreach campaign to find the right next home for Art Pharma®.

View Complete Asset List — Domains, Trademarks & NPNs

BRANDS, INTELLECTUAL PROPERTY & REGULATORY

1. ART PHARMA

https://artpharma.com

  • Domain Names: artpharma.com + 6 variations
  • Trademarks: ART PHARMA — Canada and USA
  • History: 10 years of brand history across the brands listed below

2. LUGOL

https://lugol.com

  • Domain Names: lugol.com + 32 variations
  • Trademarks: ART PHARMA LUGOL IODINE SOLUTION — Canada and USA
  • Natural Product Numbers (NPNs): 6

3. KI SOLUTION

https://kisolution.com

  • Domain Names: kisolution.com + 9 variations
  • Trademarks: ART PHARMA KI SOLUTION — Canada and USA
  • Natural Product Numbers (NPNs): 1

4. KI SOLUTION PLUS

https://kisolutionplus.com

  • Domain Names: kisolutionplus.com + 7 variations
  • Trademarks: ART PHARMA KI SOLUTION PLUS — Canada and USA
  • Natural Product Numbers (NPNs): 1

OPTIONAL PIPELINE

Details Available Upon Request

Additional intellectual property and regulatory assets with no sales history.

LUGOL Related

  • 4 domain names
  • 5 Natural Product Numbers (NPNs)

KI SOLUTION Related

  • 4 domain names
  • 1 Natural Product Number (NPN)

Art Pharma®

NEWS RELEASE

Thursday, November 12, 2026

Decision by December 31, 2026

Art Pharma products are currently unavailable, and we do not have a confirmed restock date.

After more than 10 years in the iodine supplementation market, Art Pharma has reached a point where its next stage requires a decision.

We are currently considering two paths.

Acquisition of the Brand & Intellectual Property

The complete acquisition of the Art Pharma® (Canada & USA) brand and the associated intellectual property and digital assets.

This represents a different path: ownership and control of the acquired assets would transfer to the purchaser.

Founder Funded

The opportunity is to move beyond simply selling Lugol’s iodine online and bring iodine supplementation closer to people through education and personal interaction. 

Executing the plan requires a significant capital investment and the founder’s time at a point when the main chemical distribution business is entering its next stage of growth.

Whether that investment of capital and time makes sense is the decision that must now be made.

For Our Customers

To the customers who continue to visit, write and ask when our products will return: thank you.

This decision is being made carefully because what happens next matters.

We will announce Art Pharma’s direction no later than December 31, 2026.